Learn more about Reblozyl^® by visiting the product website or by downloading prescribing information

For Patients

For Healthcare Providers

© 2020 Celgene Corporation.
REBLOZYL is a trademark of Celgene Corporation, a Bristol Myers Squibb Company.
REBLOZYL is licensed from Acceleron Pharma Inc. 10/20 US-RBZ-20-0424